Q3

Windlas Biotech Ltd

WINDLASFY2511 Feb 2025

Revenue+4.3%

Net Profit-0.5%

OPM4.02%

P&L

Quarterly Consolidated

Revenue

+4.3%195.02

Expenditure

+4.2%178.79

Net Profit

-0.5%15.58

NPM 7.82%-4.2%EPS ₹7.45-0.5%

vs Q2 FY25

Informational and educational content only. Not investment advice.